Private biotech 2004—the numbers

被引：0

作者：

John Hodgson

机构：

[1] Editor-at-Large for Nature Biotechnology and a director of Critical I Limited,

[2] The Colin Sanders Innovation Centre,undefined

来源：

Nature Biotechnology | 2006年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.

引用

页码：635 / 641

页数：6

共 50 条

[41] Public biotech in 2017-the numbers
Morrison, Chris
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2018, 36 (07) : 576 - 584
[42] Public biotech 2010-the numbers
Huggett, Brady
Hodgson, John
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2011, 29 (07) : 585 - 591
[43] Public biotech in 2016-the numbers
Morrison, Chris
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2017, 35 (07) : 623 - 629
[44] Public biotech in 2015-the numbers
Morrison, Chris
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2016, 34 (07) : 709 - 715
[45] Public biotech 2011-the numbers
Huggett, Brady
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2012, 30 (08) : 751 - 757
[46] Public biotech 2009-the numbers
Huggett, Brady
Hodgson, John
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2010, 28 (08) : 793 - 799
[47] Public biotech 2013-the numbers
Lawrence, Stacy
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2014, 32 (07) : 626 - 632
[48] Public biotech in 2021-the numbers
DeFrancesco, Laura
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2022, 40 (10) : 1427 - 1427
[49] Public biotech 2008-the numbers
Huggett, Brady
Hodgson, John
Lahteenmaki, Riku
[J]. NATURE BIOTECHNOLOGY, 2009, 27 (08) : 710 - 721
[50] Erratum: Public Biotech 2012—the numbers
Brady Huggett
[J]. Nature Biotechnology, 2013, 31 (12) : 1148 - 1148

← 1 2 3 4 5 →